has_Ingredient has_MoA has_PE drug associated with AE in adult drug associated with AE in senior drug associated with AE in pediatric used to treat disease Increased T Lymphocyte Destruction [PE] imatinib [Chemical/Ingredient] I [Preparations] Bcr-Abl Tyrosine Kinase Inhibitors [MoA] IMATINIB http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021588s030s031lbl.pdf Active N0000148698 C53876 C0935989 4021257 Ingredient <VANDF_Record>50.6^3696^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>3696</VA_IEN> BKJ8M8G5HI <VANDF_Record>50.416^3929^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>3929</VA_IEN> IMATINIB imatinib 282388 dermatofibrosarcoma protuberans aggressive systemic mastocytosis myelodysplastic/myeloproliferative neoplasm chronic myeloid leukemia gastrointestinal stromal tumor acute lymphocytic leukemia hypereosinophilic syndrome fatigue AE dyspnea AE lacrimation increased AE rhinitis AE fever AE rash AE pruritus AE myalgia AE arthralgia AE edema limbs AE anorexia AE face edema AE abdominal pain AE ascites AE anemia AE edema AE nausea AE vomiting AE constipation AE diarrhea AE musculoskeletal pain AE periorbital edema AE lower respiratory tract infection AE muscle cramp AE heartburn AE stomach pain AE eye edema AE